Clinuvel Pharmaceuticals Ltd. (CUVL) Financials
CUVL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 178.7 million | 20.3 million |
CUVL Free Cash Flow and Stock based compensation
No data available :(
CUVL Net Income
No data available :(
CUVL Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | - | - | 347567 |
CUVL Shares Outstanding
CUVL Expenses
No data available :(
CUVL Cost of Revenue
No data available :(
CUVL
Price: $5.07
Dividend Yield: 0.49%
Forward Dividend Yield: 0.57%
Dividend Per Share: 0.03 USD
Earnings Per Share: 0.50 USD
P/E Ratio: 12.48
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 292.5 million
Average Dividend Frequency: 1
Years Paying Dividends: 1